Cetera Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $5.88M | Buy |
11,335
+5,372
| +90% | +$2.67M | 0.05% | 404 |
|
|
2023
Q4 | $2.81M | Buy |
5,963
+1,372
| +30% | +$634K | 0.04% | 408 |
|
|
2023
Q3 | $2M | Buy |
4,591
+387
| +9% | +$176K | 0.03% | 466 |
|
|
2023
Q2 | $1.87M | Buy |
4,204
+144
| +4% | +$66.4K | 0.03% | 485 |
|
|
2023
Q1 | $1.87M | Sell |
4,060
-307
| -7% | -$146K | 0.03% | 469 |
|
|
2022
Q4 | $2.24M | Sell |
4,367
-1,737
| -28% | -$882K | 0.04% | 409 |
|
|
2022
Q3 | $3K | Buy |
6,104
+3,237
| +113% | +$1.55M | ﹤0.01% | 1288 |
|
|
2022
Q2 | $1.38M | Buy |
2,867
+114
| +4% | +$56.4K | 0.03% | 478 |
|
|
2022
Q1 | $1.35M | Buy |
2,753
+722
| +36% | +$330K | 0.03% | 513 |
|
|
2021
Q4 | $941K | Sell |
2,031
-313
| -13% | -$132K | 0.02% | 631 |
|
|
2021
Q3 | $874K | Buy |
2,344
+703
| +43% | +$267K | 0.02% | 660 |
|
|
2021
Q2 | $626K | Sell |
1,641
-65
| -4% | -$24.8K | 0.01% | 722 |
|
|
2021
Q1 | $613K | Buy |
1,706
+628
| +58% | +$202K | 0.02% | 659 |
|
|
2020
Q4 | $346K | Buy |
1,078
+120
| +13% | +$36.8K | 0.01% | 775 |
|
|
2020
Q3 | $257K | Sell |
958
-18
| -2% | -$4.84K | 0.01% | 796 |
|
|
2020
Q2 | $257K | Sell |
976
-111
| -10% | -$29.6K | 0.01% | 756 |
|
|
2020
Q1 | $247K | Buy |
1,087
+231
| +27% | +$63K | 0.01% | 658 |
|
|
2019
Q4 | $259K | Buy |
+856
| New | +$236K | 0.01% | 769 |
|
|
2019
Q3 | – | Sell |
-2,077
| Closed | -$586K | – | 912 |
|
|
2019
Q2 | $586K | Sell |
2,077
-37
| -2% | -$10.1K | 0.03% | 518 |
|
|
2019
Q1 | $607K | Sell |
2,114
-90
| -4% | -$26K | 0.03% | 448 |
|
|
2018
Q4 | $579K | Sell |
2,204
-54
| -2% | -$14.8K | 0.03% | 435 |
|
|
2018
Q3 | $617K | Buy |
2,258
+11
| +0.5% | +$2.86K | 0.03% | 485 |
|
|
2018
Q2 | $536K | Buy |
2,247
+20
| +0.9% | +$4.63K | 0.03% | 490 |
|
|
2018
Q1 | $491K | Sell |
2,227
-327
| -13% | -$76.8K | 0.03% | 477 |
|
|
2017
Q4 | $574K | Buy |
2,554
+120
| +5% | +$25.6K | 0.04% | 405 |
|
|
2017
Q3 | $465K | Buy |
+2,434
| New | +$463K | 0.03% | 486 |
|
|
2015
Q3 | – | Sell |
-2,076
| Closed | -$340K | – | 696 |
|
|
2015
Q2 | $340K | Sell |
2,076
-14
| -0.7% | -$2.24K | 0.03% | 475 |
|
|
2015
Q1 | $323K | Buy |
2,090
+195
| +10% | +$27.8K | 0.03% | 481 |
|
|
2014
Q4 | $236K | Buy |
1,895
+76
| +4% | +$9.39K | 0.02% | 550 |
|
|
2014
Q3 | $218K | Buy |
+1,819
| New | +$209K | 0.02% | 526 |
|
Other funds holding ELV
Cetera Advisors's ELV Position: Q1 2024 in Review
Cetera Advisors increased its Elevance Health (ELV) stake by 90% in Q1 2024, buying an estimated $2.67M and bringing the position to 11,335 shares worth $5.88M. The position accounts for 0.05% of the portfolio, ranked #404.
Cetera Advisors first reported a position in ELV in Q3 2014 and has held it in 30 quarters since. 1,666 funds tracked by Wall St. Rank hold ELV as of Q1 2024.
- Cetera Advisors held 11,335 shares of Elevance Health worth $5.88M as of Q1 2024.
- Cetera Advisors bought 5,372 Elevance Health shares in Q1 2024, an estimated $2.67M.
- Elevance Health made up 0.05% of Cetera Advisors's portfolio in Q1 2024, its #404 holding.
- Cetera Advisors first reported a position in Elevance Health in Q3 2014 and has held it in 30 quarters since.
- 1,666 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.
Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.